Stonepine Capital Management, LLC 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Stonepine Capital Management, LLC disclosed 66 US equity positions worth $102.8m in its Q1 2025 13F filing. The largest position was EOLS at 13.3% of the reported book, followed by ANIP and OPTNUSD. Against the Q4 2024 filing, it opened 13 new positions, added to 16 and reduced 18 among the top 50 holdings.
What did Stonepine Capital Management, LLC own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | EOLS EVOLUS INC | Healthcare | 13.3% | $13.6m | 1,134,574 | -10% | reduced |
| 2 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 13.3% | $13.6m | 48,000 | 135% | added |
| 3 | OPTNUSD OPTINOSE INC | 7.0% | $7.2m | 788,647 | 34% | added | |
| 4 | ZVRA ZEVRA THERAPEUTICS INC | 4.7% | $4.9m | 650,000 | 9% | added | |
| 5 | VSTM VERASTEM INC | Healthcare | 3.6% | $3.7m | 613,000 | -30% | reduced |
| 6 | URGN UROGEN PHARMA LTD | Healthcare | 3.6% | $3.7m | 333,400 | 3% | added |
| 7 | SRZN SURROZEN INC | 3.2% | $3.3m | 285,782 | 108% | added | |
| 8 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 3.2% | $3.3m | 206,639 | -13% | reduced |
| 9 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 3.2% | $3.3m | 590,742 | 78% | added |
| 10 | AQST AQUESTIVE THERAPEUTICS INC | 3.0% | $3.0m | 200,000 | 25% | added | |
| 11 | ESTA ESTABLISHMENT LABS HLDGS INC | Healthcare | 3.0% | $3.0m | 74,500 | -7% | reduced |
| 12 | INDIVIOR PLC | 2.8% | $2.9m | 304,000 | -0% | held | |
| 13 | ACRS ACLARIS THERAPEUTICS INC | Healthcare | 2.7% | $2.8m | 527,842 | -20% | reduced |
| 14 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.7% | $2.8m | 348,820 | 48% | added | |
| 15 | XOMA ROYALTY CORPORATION | 2.5% | $2.6m | 129,813 | 3% | added | |
| 16 | TELA TELA BIO INC | 2.4% | $2.5m | 2,055,225 | -13% | reduced | |
| 17 | LKFT GALAPAGOS NV | Healthcare | 2.3% | $2.4m | 93,968 | -53% | reduced |
| 18 | IKT INHIBIKASE THERAPEUTICS INC | 1.9% | $2.0m | 914,973 | -19% | reduced | |
| 19 | HRTX HERON THERAPEUTICS INC | Healthcare | 1.7% | $1.8m | 796,100 | 14% | added |
| 20 | EDSA EDESA BIOTECH INC | 1.6% | $1.7m | 687,500 | – | new | |
| 21 | MYO MYOMO INC | 1.3% | $1.3m | 276,707 | 1% | added | |
| 22 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.0% | $1.0m | 100,000 | – | new |
| 23 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.9% | $937.2k | 144,628 | -12% | reduced |
| 24 | SCPH SCPHARMACEUTICALS INC | 0.9% | $914.4k | 347,687 | -49% | reduced | |
| 25 | INO INOVIO PHARMACEUTICALS INC | 0.8% | $844.9k | 518,331 | -51% | reduced | |
| 26 | PROF PROFOUND MEDICAL CORP | 0.8% | $814.5k | 139,942 | -30% | reduced | |
| 27 | AYTU AYTU BIOPHARMA INC | 0.8% | $795.0k | 463,721 | 14% | added | |
| 28 | GERN GERON CORP | Healthcare | 0.8% | $795.0k | 500,000 | – | new |
| 29 | THIRD HARMONIC BIO INC | 0.7% | $738.4k | 212,783 | – | new | |
| 30 | PMVP PMV PHARMACEUTICALS INC | 0.7% | $686.9k | 630,183 | 18% | added | |
| 31 | GRCE GRACE THERAPEUTICS INC | 0.6% | $665.7k | 294,550 | – | new | |
| 32 | 2662247D ITEOS THERAPEUTICS INC | 0.6% | $656.7k | 110,000 | 0% | held | |
| 33 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 0.6% | $615.1k | 20,607 | – | new |
| 34 | CALC CALCIMEDICA INC | 0.6% | $615.1k | 367,371 | -22% | reduced | |
| 35 | KPRX KIORA PHARMACEUTICALS INC | 0.6% | $603.9k | 200,647 | -0% | held | |
| 36 | YMABUSD Y-MABS THERAPEUTICS INC | 0.6% | $581.0k | 131,160 | – | new | |
| 37 | XERS XERIS BIOPHARMA HOLDINGS INC | Healthcare | 0.5% | $561.4k | 102,265 | -44% | reduced |
| 38 | CHRS COHERUS BIOSCIENCES INC | Healthcare | 0.5% | $500.8k | 620,588 | 148% | added |
| 39 | 2KZ0 KEZAR LIFE SCIENCES INC | 0.5% | $488.0k | 100,000 | -9% | reduced | |
| 40 | ACELYRIN INC | 0.4% | $413.9k | 167,580 | 26% | added | |
| 41 | NBP I MAB | Healthcare | 0.4% | $398.5k | 483,647 | – | new |
| 42 | SEPN SEPTERNA INC | 0.4% | $394.2k | 68,084 | – | new | |
| 43 | HILLEVAX INC | 0.3% | $346.5k | 238,950 | 81% | added | |
| 44 | XGN EXAGEN INC | 0.3% | $343.7k | 95,747 | -62% | reduced | |
| 45 | RNXT RENOVORX INC | 0.3% | $275.4k | 278,188 | – | new | |
| 46 | 4XC1 KALVISTA PHARMACEUTICALS INC | 0.2% | $248.7k | 21,550 | – | new | |
| 47 | ACET ADICET BIO INC | Healthcare | 0.2% | $203.5k | 508,266 | -27% | reduced |
| 48 | CRGX CARGO THERAPEUTICS INC | 0.2% | $203.5k | 50,000 | – | new | |
| 49 | MIST MILESTONE PHARMACEUTICALS IN | 0.2% | $200.0k | 250,000 | -50% | reduced | |
| 50 | BIOA BIOAGE LABS INC | 0.2% | $188.0k | 50,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.